{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:50:34Z","timestamp":1789959034453,"version":"4.0.1"},"reference-count":29,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background: Healthcare-associated infections (HAIs) and antimicrobial resistance are major burdens in tertiary care hospitals. Repeated point prevalence surveys (PPSs) offer a pragmatic approach to monitor temporal changes and guide infection prevention. Objectives: Characterize healthcare-associated infections (HAI) prevalence trends, microbiological profiles, antimicrobial resistance (AMR) patterns, and risk factors to refine prevention strategies and hospital policy. Methods: Four annual cross-sectional PPSs were conducted between 2022 and 2025 using the standardized ECDC protocol. Data from all eligible inpatients present at 08:00 on survey days were collected through systematic medical record review. Multivariable logistic regression was used to identify factors independently associated with HAI, with additional sensitivity analyses evaluating invasive device burden and hospital ward type. Results: Across the surveys, 3314 patients were included. Overall HAI prevalence was 11.3%. Infections were most frequent in intensive care units (31.2%), followed by medical (14.6%) and surgical (14.2%) wards. Bloodstream infections (25.7%) and lower respiratory tract infections (19.8%) were the most common. Multivariable analysis identified invasive device exposure as the strongest predictor, with central venous and urinary catheters showing robust independent associations and a clear dose\u2013response relationship according to the number of devices. Pathogens were predominantly Gram-positive cocci (40.5%) and Enterobacterales (30.8%), with Klebsiella pneumoniae being the most frequent isolate (13.0%). Notably, 57.6% of K. pneumoniae isolates were resistant to third-generation cephalosporins. All tested Acinetobacter baumannii isolates were resistant to carbapenems. Conclusions: This repeated PPS reveals a persistently high HAI burden, associated with invasive device exposure and resistant pathogens. Because of the repeated cross-sectional design, causal inference cannot be established. Hospital-wide device stewardship and integrated surveillance are essential for guiding targeted prevention measures, refining antimicrobial policies, and adapting local responses to evolving resistance profiles.<\/jats:p>","DOI":"10.3390\/antibiotics15070641","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:11:57Z","timestamp":1782785517000},"page":"641","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in Healthcare-Associated Infections Prevalence and Risk Factors: Repeated Point Prevalence Survey in a Milan Tertiary Hospital (2022\u20132025)"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9185-9747","authenticated-orcid":false,"given":"Flavia","family":"Pennisi","sequence":"first","affiliation":[{"name":"National PhD Program in One Health Approaches to Infectious Diseases and Life Science Research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy"},{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1098-6929","authenticated-orcid":false,"given":"Martino Alberto","family":"Godoy","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9459-9754","authenticated-orcid":false,"given":"Tommaso","family":"Camuffo","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6802-1448","authenticated-orcid":false,"given":"Sabrina","family":"Caruccio","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2982-3105","authenticated-orcid":false,"given":"Giusy","family":"D\u2019Alterio","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Nebbia","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Simone","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sarabhai Verma","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9710-4962","authenticated-orcid":false,"given":"Carlo","family":"Signorelli","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Rezza","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5398-6000","authenticated-orcid":false,"given":"Matteo","family":"Moro","sequence":"additional","affiliation":[{"name":"Infection Control Committee, IRCCS San Raffaele Hospital, 20132, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100391","DOI":"10.1016\/j.infpip.2024.100391","article-title":"Device associated healthcare associated infection (DA-HAI): A detailed analysis of risk factors and outcomes in a university hospital in Rome, Italy","volume":"6","author":"Guarente","year":"2024","journal-title":"Infect. Prev. Pract."},{"key":"ref_2","unstructured":"Tobin, E.H., and Zahra, F. (2026). Nosocomial Infections, StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Pennisi, F., Borlini, S., Cuciniello, R., D\u2019Amelio, A.C., Calabretta, R., Pinto, A., and Signorelli, C. (2025). Improving Vaccine Coverage Among Older Adults and High-Risk Patients: A Systematic Review and Meta-Analysis of Hospital-Based Strategies. Healthcare, 13.","DOI":"10.3390\/healthcare13141667"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e70168","DOI":"10.1002\/hsr2.70168","article-title":"The Extra Length of Stay, Costs, and Mortality Associated With Healthcare-Associated Infections: A Case-Control Study","volume":"7","author":"Moradi","year":"2024","journal-title":"Health Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100406","DOI":"10.1016\/j.infpip.2024.100406","article-title":"The financial burden of healthcare-associated infections: A propensity score analysis in an Italian healthcare setting","volume":"7","author":"Orlando","year":"2025","journal-title":"Infect. Prev. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1007\/s00134-018-5113-0","article-title":"ECDC definitions and methods for the surveillance of healthcare-associated infections in intensive care units","volume":"44","author":"Plachouras","year":"2018","journal-title":"Intensive Care Med."},{"key":"ref_7","unstructured":"European Centre for Disease Prevention and Control (2024). Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals, ECDC. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/PPS-HAI-AMR-acute-care-europe-2022-2023."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/ebnurs-2022-103540","article-title":"Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"27","author":"Ranjbar","year":"2024","journal-title":"Evid. Based Nurs."},{"key":"ref_9","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators (2024). Global burden of bacterial antimicrobial resistance 1990\u20132021: A systematic analysis with forecasts to 2050. Lancet, 404, 1199\u20131226."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO Bacterial Priority Pathogens List 2024: A prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pinto, A., Pennisi, F., Odelli, S., De Ponti, E., Veronese, N., Signorelli, C., Baldo, V., and Gianfredi, V. (2025). Artificial Intelligence in the Management of Infectious Diseases in Older Adults: Diagnostic, Prognostic, and Therapeutic Applications. Biomedicines, 13.","DOI":"10.3390\/biomedicines13102525"},{"key":"ref_12","unstructured":"Ethiopia Ministry of Health (2026, April 01). National Healthcare Associated Infections (HAIs) Surveillance Guideline. Available online: https:\/\/resolvetosavelives.org\/wp-content\/uploads\/2025\/05\/National_Healthcare_Associated_Infections_HAIs_Surveillance_Guidance.pdf."},{"key":"ref_13","unstructured":"Ministero della Salute (2026, March 10). Indagine di Prevalenza delle Infezioni Correlate all\u2019Assistenza e sull\u2019Uso di Antibiotici Negli Ospedali Italiani, Available online: https:\/\/www.salute.gov.it\/portale\/documentazione\/p6_2_2_1.jsp?lingua=italiano&id=3297."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1800516","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800516","article-title":"Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: Results from two European point prevalence surveys, 2016 to 2017","volume":"23","author":"Suetens","year":"2018","journal-title":"Eurosurveillance"},{"key":"ref_15","first-page":"234","article-title":"Quality of hospital care and clinical outcomes: A comparison between the Lombardy Region and the Italian national data","volume":"36","author":"Signorelli","year":"2024","journal-title":"Ann. Ig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in Prevalence of Health Care\u2013Associated Infections in U.S. Hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate Point-Prevalence Survey of Health Care\u2013Associated Infections","volume":"370","author":"Magill","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/CCM.0b013e31824e0d46","article-title":"Dressing disruption is a major risk factor for catheter-related infections","volume":"40","author":"Timsit","year":"2012","journal-title":"Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-114-10-845","article-title":"Risk Factors for Infusion-related Phlebitis with Small Peripheral Venous Catheters","volume":"114","author":"Maki","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1473-3099(14)70854-0","article-title":"Hospital organisation, management, and structure for prevention of health-care-associated infection: A systematic review and expert consensus","volume":"15","author":"Zingg","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/668422","article-title":"On the Role of Length of Stay in Healthcare-Associated Bloodstream Infection","volume":"33","author":"Jeon","year":"2012","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1055\/s-0038-1656535","article-title":"Presence of Invasive Devices and Risks of Healthcare-Associated Infections and Sepsis","volume":"07","author":"Bennett","year":"2018","journal-title":"J. Pediatr. Intensive Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2147\/IDR.S459739","article-title":"The Distribution of Carbapenem-Resistant Acinetobacter Species and High Prevalence of CC92 OXA-23-Producing Acinetobacter Baumannii in Community Hospitals in South Korea","volume":"17","author":"Bae","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1093\/jac\/dkae358","article-title":"Overall status of carbapenem resistance among clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis","volume":"79","author":"Ghahramani","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.idh.2019.03.001","article-title":"Effectiveness of insertion and maintenance bundles in preventing peripheral intravenous catheter-related complications and bloodstream infection in hospital patients: A systematic review","volume":"24","author":"Xu","year":"2019","journal-title":"Infect. Dis. Health"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ko\u0142pa, M., Wa\u0142aszek, M., R\u00f3\u017ca\u0144ska, A., Wolak, Z., and W\u00f3jkowska-Mach, J. (2018). Hospital-Wide Surveillance of Healthcare-Associated Infections as a Source of Information about Specific Hospital Needs. A 5-Year Observation in a Multiprofile Provincial Hospital in the South of Poland. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15091956"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1093\/jac\/dkaa425","article-title":"Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: The COMBACTE-Magnet EPI-Net COACH project","volume":"75","author":"Pezzani","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Darboe, S., Mirasol, R., Adejuyigbe, B., Muhammad, A.K., Nadjm, B., De St Maurice, A., Dogan, T.L., Ceesay, B., Umukoro, S., and Okomo, U. (2023). Using an Antibiogram Profile to Improve Infection Control and Rational Antimicrobial Therapy in an Urban Hospital in The Gambia, Strategies and Lessons for Low- and Middle-Income Countries. Antibiotics, 12.","DOI":"10.3390\/antibiotics12040790"},{"key":"ref_29","unstructured":"European Centre for Disease Prevention and Control (2022). Sorveglianza Europea Mediante Prevalenza Puntuale delle Infezioni Correlate all\u2019Assistenza e sull\u2019Uso di Antibiotici Negli Ospedali per Acuti: Protocollo per Sorveglianza Standard, Versione 6.0, ECDC PPS 2022-2023; Versione Italiana, ECDC. Available online: https:\/\/www.epicentro.iss.it\/sorveglianza-ica\/pdf\/Protocollo%20ITA%202022-2023.FINALE.pdf."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/641\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:14:21Z","timestamp":1782792861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/7\/641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["antibiotics15070641"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15070641","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]}}}